In post‐mortem human brain, APOE ε4 carriers showed reduced synaptic proteins, reduced mitochondrial fusion/fission, biogenesis, and superoxide dismutase proteins irrespective of AD diagnosis (Yin et al., 2020). Here, APOE is linked to Alzheimer disease.